Moderna mRNA flu OK

US FDA Approves First mRNA Flu Vaccine

The FDA approved Moderna's mFLUSIVA, the first mRNA-based influenza vaccine, for US adults aged 50 and older in the 2026–27 flu season. This milestone marks a key modernization step in vaccine develop